5/17
03:19 am
nby
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/13
11:28 am
nby
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Neutral
Report
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/13
08:30 am
nby
NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
Low
Report
NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
5/9
04:12 pm
nby
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/9
04:05 pm
nby
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
Medium
Report
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
5/9
03:31 am
nby
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/7
08:00 am
nby
NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
Medium
Report
NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
5/3
07:00 am
nby
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024 [Yahoo! Finance]
Medium
Report
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024 [Yahoo! Finance]
5/3
06:50 am
nby
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
Medium
Report
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
5/1
02:04 am
nby
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/23
02:01 am
nby
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/22
07:15 am
nby
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales [Yahoo! Finance]
High
Report
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales [Yahoo! Finance]
4/22
06:57 am
nby
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
Medium
Report
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
4/19
06:08 pm
nby
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity [Yahoo! Finance]
High
Report
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity [Yahoo! Finance]
4/19
06:00 pm
nby
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
High
Report
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
4/17
07:12 am
nby
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses [Yahoo! Finance]
Low
Report
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses [Yahoo! Finance]
4/17
06:59 am
nby
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
Medium
Report
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
4/15
02:01 am
nby
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/7
02:09 am
nby
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/30
02:05 am
nby
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/26
04:18 pm
nby
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results [Yahoo! Finance]
High
Report
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results [Yahoo! Finance]
3/26
04:05 pm
nby
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
High
Report
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
3/25
06:44 pm
nby
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 [Yahoo! Finance]
Medium
Report
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 [Yahoo! Finance]
3/25
06:38 pm
nby
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
Medium
Report
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
3/22
02:04 am
nby
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.